Osteoinductive potential of 4 commonly employed bone grafts
- 1.4k Downloads
Guided bone regeneration (GBR) aims to predictably restore missing bone that has been lost due to trauma, periodontal disease or a variety of systemic conditions. Critical to this procedure is the ability of a bone grafting material to predictably serve as a 3-dimensional scaffold capable of inducing cell and bone tissue in-growth at the material surface. Although all bone grafts are osteoconductive to bone-forming osteoblasts, only a small number of commercially available bone grafts with FDA approval are osteoinductive including demineralized freeze-dried bone allographs (DFDBA) and scaffolds containing bone morphogenetic proteins (BMPs). Recently, a class of synthetic bone grafts fabricated from biphasic calcium phosphate (BCP) sintered at a low temperature have been shown to form ectopic bone formation in non-skeletal sites without the use of growth factors. Therefore, the present study aimed to compare the osteoinductive potential of this group of synthetic BCP alloplasts with autografts, allografts and xenografts.
Materials and methods
In the present study, 4 types of bone grafting materials including autogenous bone harvested with a bone mill, DFDBA (LifeNet, USA), a xenograft derived from bovine bone mineral (NBM, BioOss, Geistlich, Switzerland) and a novel synthetic biphasic calcium phosphate (BCP, Straumman, Switzerland) were implanted into intramuscular pouches of 24 rats and analysed histologically for their ability to form ectopic bone formation around grafting particles. A semi-quantitative osteoinductive score was used to quantify the osteoinductive ability of each bone graft.
The results from the present study reveal that (1) autogenous bone resorbed rapidly in vivo, (2) the xenograft showed no potential to form ectopic bone formation and (3) both DFDBA and BCP were able to stimulate ectopic bone formation.
These studies demonstrate that these newly developed synthetic bone grafts have potential for inducing ectopic bone formation similar to DFDBA. Future clinical testing is necessary to reveal their bone-inducing properties in clinical scenarios including GBR procedures and in combination with implant dentistry.
Novel BCP scaffolds are able to induce ectopic bone formation without the use of osteoinductive growth factors such as BMP2 and thus demonstrate a large clinical possibility to further enhance bone formation for a variety of clinical procedures.
KeywordsOsteoinduction Osteoinductive potential Bone grafts Natural bone mineral
Compliance with ethical standards
Conflict of interest
BCP grafts were kindly provided by Straumann AG, Switzerland. Benjamin Pippenger and Michel Dard are both employees of Straumann AG who contributed to the experimental design and provided the bone grafting materials. All other authors declare no conflict of interest.
This study was supported by a grant from the American Academy of Implant Dentistry to Richard J. Miron (2013).
All applicable international, national and/or institutional guidelines for the care and use of animals were followed by the University of Wuhan, Department of Oral Implantology, China.
No informed patient consent was necessary.
- 1.Jensen SS, Bornstein MM, Dard M, Bosshardt DD, Buser D (2009) Comparative study of biphasic calcium phosphates with different HA/TCP ratios in mandibular bone defects. A long-term histomorphometric study in minipigs. J Biomed Mater Res B Appl Biomater 90:171–181. doi: 10.1002/jbm.b.31271 PubMedGoogle Scholar
- 9.Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A, Walsh WR, van Blitterswijk CA, de Bruijn JD (2010) Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci U S A 107:13614–13619. doi: 10.1073/pnas.1003600107 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Miron RJ, Bosshardt DD, Gemperli AC, Dard M, Buser D, Gruber R, Sculean A (2014) In vitro characterization of a synthetic calcium phosphate bone graft on periodontal ligament cell and osteoblast behavior and its combination with an enamel matrix derivative. Clin Oral Investig 18:443–451. doi: 10.1007/s00784-013-0977-4 CrossRefPubMedGoogle Scholar
- 21.Schwartz Z, Mellonig JT, Carnes Jr DL, de la Fontaine J, Cochran DL, Dean DD, Boyan BD (1996) Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation. J Periodontol 67:918–926. doi: 10.1902/jop.19220.127.116.118
- 29.Bornstein MM, Chappuis V, von Arx T, Buser D (2008) Performance of dental implants after staged sinus floor elevation procedures: 5-year results of a prospective study in partially edentulous patients. Clin Oral Implants Res 19:1034–1043. doi: 10.1111/j.1600-0501.2008.01573.x CrossRefPubMedGoogle Scholar
- 30.Jensen SS, Aaboe M, Janner SF, Saulacic N, Bornstein MM, Bosshardt DD, Buser D (2013) Influence of particle size of deproteinized bovine bone mineral on new bone formation and implant stability after simultaneous sinus floor elevation: a histomorphometric study in minipigs. Clin Oral Implants Res. doi: 10.1111/cid.12101 PubMedGoogle Scholar
- 31.Jensen SS, Bosshardt DD, Gruber R and Buser D (2014) Long-term stability of contour augmentation in the esthetic zone. Histologic and histomorphometric evaluation of 12 human biopsies 14 to 80 months after augmentation. J Periodontol:1–15. doi: 10.1902/jop.2014.140182
- 33.Schwartz Z, Somers A, Mellonig JT, Carnes Jr DL, Dean DD, Cochran DL, Boyan BD (1998) Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J Periodontol 69:470–478. doi: 10.1902/jop.1918.104.22.1680
- 34.Davison NL, Gamblin AL, Layrolle P, Yuan H, de Bruijn JD, Barrere-de Groot F (2014) Liposomal clodronate inhibition of osteoclastogenesis and osteoinduction by submicrostructured beta-tricalcium phosphate. Biomaterials 35:5088–5097. doi: 10.1016/j.biomaterials.2014.03.013 CrossRefPubMedGoogle Scholar